| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers
|
Laitman, Yael
|
|
2015
|
150 |
3 |
p. 631-635
|
article
|
| 2 |
CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancer
|
Conley, Sarah J.
|
|
2015
|
150 |
3 |
p. 559-567
|
article
|
| 3 |
Diagnostic accuracy of sentinel node identification is maintained with the addition of local lidocaine and subareolar radioactive colloid injection
|
Stearns, Vered
|
|
2015
|
150 |
3 |
p. 589-595
|
article
|
| 4 |
Differential effects of superoxide dismutase and superoxide dismutase/catalase mimetics on human breast cancer cells
|
Shah, Manisha H.
|
|
2015
|
150 |
3 |
p. 523-534
|
article
|
| 5 |
Erratum to: Platinum-based chemotherapy in triple-negative advanced breast cancer
|
Villarreal-Garza, Cynthia
|
|
2015
|
150 |
3 |
p. 697
|
article
|
| 6 |
Erratum to: Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history
|
Kang, Peter Choon Eng
|
|
2015
|
150 |
3 |
p. 699-700
|
article
|
| 7 |
Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer
|
Zhu, X.
|
|
2015
|
150 |
3 |
p. 479-486
|
article
|
| 8 |
Impact of breast cancer subtypes and patterns of metastasis on outcome
|
Kast, Karin
|
|
2015
|
150 |
3 |
p. 621-629
|
article
|
| 9 |
miR-153 inhibits epithelial–mesenchymal transition by targeting metadherin in human breast cancer
|
Li, Wentong
|
|
2015
|
150 |
3 |
p. 501-509
|
article
|
| 10 |
Note of clarification of data in the paper entitled association between BRIP1 (BACH1) polymorphisms and breast cancer risk
|
Wang, Yadong
|
|
2015
|
150 |
3 |
p. 467-471
|
article
|
| 11 |
Novel role of PELP1 in regulating chemotherapy response in mutant p53-expressing triple negative breast cancer cells
|
Krishnan, Samaya R.
|
|
2015
|
150 |
3 |
p. 487-499
|
article
|
| 12 |
Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium
|
Bandera, Elisa V.
|
|
2015
|
150 |
3 |
p. 655-666
|
article
|
| 13 |
Overall survival (OS) endpoint: an incomplete evaluation of metastatic breast cancer (MBC) treatment outcome
|
Raphael, Jacques
|
|
2015
|
150 |
3 |
p. 473-478
|
article
|
| 14 |
PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers
|
Stanley, Jennifer
|
|
2015
|
150 |
3 |
p. 569-579
|
article
|
| 15 |
Personality and breast cancer risk and survival: the Miyagi Cohort Study
|
Minami, Yuko
|
|
2015
|
150 |
3 |
p. 675-684
|
article
|
| 16 |
Prevalence of PALB2 mutations in the Creighton University Breast Cancer Family Registry
|
Snyder, C.
|
|
2015
|
150 |
3 |
p. 637-641
|
article
|
| 17 |
Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer
|
Abduljabbar, Rezvan
|
|
2015
|
150 |
3 |
p. 511-522
|
article
|
| 18 |
Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer
|
Lohmann, Ana Elisa
|
|
2015
|
150 |
3 |
p. 605-611
|
article
|
| 19 |
Quantitative assessment of HER2 amplification in HER2-positive breast cancer: its association with clinical outcomes
|
Xuan, Qijia
|
|
2015
|
150 |
3 |
p. 581-588
|
article
|
| 20 |
Race, response to chemotherapy, and outcome within clinical breast cancer subtypes
|
Tichy, J. R.
|
|
2015
|
150 |
3 |
p. 667-674
|
article
|
| 21 |
Retrospective analysis of metastatic behaviour of breast cancer subtypes
|
Savci-Heijink, C. Dilara
|
|
2015
|
150 |
3 |
p. 547-557
|
article
|
| 22 |
Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women
|
Rosner, Bernard
|
|
2015
|
150 |
3 |
p. 643-653
|
article
|
| 23 |
Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer
|
Gernapudi, Ramkishore
|
|
2015
|
150 |
3 |
p. 685-695
|
article
|
| 24 |
Targeting thyroid hormone receptor beta in triple-negative breast cancer
|
Gu, Guowei
|
|
2015
|
150 |
3 |
p. 535-545
|
article
|
| 25 |
The association between diabetes and breast cancer stage at diagnosis: a population-based study
|
Lipscombe, Lorraine L.
|
|
2015
|
150 |
3 |
p. 613-620
|
article
|
| 26 |
The effect of YOCAS©® yoga for musculoskeletal symptoms among breast cancer survivors on hormonal therapy
|
Peppone, Luke J.
|
|
2015
|
150 |
3 |
p. 597-604
|
article
|
Journal description